NCT00231387View on ClinicalTrials.gov

Rosiglitazone And Plaque Study for Type 2 Diabetes Mellitus

PHASE3CompletedINTERVENTIONAL

Enrollment

60

Participants

Timeline

Start Date

September 30, 2002

Primary Completion Date

May 31, 2005

Study Completion Date

May 31, 2005

Conditions

Non-insulin-dependent Diabetes Mellitus

Interventions

DRUG

rosiglitazone

Trial Locations (1)

W2 1NY

GSK Clinical Trials Call Center, London

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY